世界の白癬菌薬市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Tinea Corporis Drugs Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A11954 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、白癬菌薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。白癬菌薬の種類別市場規模（抗真菌剤、ステロイド、抗感染薬組み合わせ）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・白癬菌薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Sun Pharmaceutical、Teva、Glenmark、Aurobindo、AvKare、Novartis、Sebela、Bayer ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：抗真菌剤、ステロイド、抗感染薬組み合わせ ・用途別分析2016年-2026年：病院薬局、小売薬局、オンライン薬局 ・白癬菌薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・白癬菌薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・白癬菌薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・白癬菌薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・白癬菌薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Tinea Corporis Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Tinea Corporis Drugs size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Tinea Corporis Drugs market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Tinea Corporis Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Antifungals
Steroids
Anti-Infective Combinations

Market segment by Application, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market segment by players, this report covers
Sun Pharmaceutical
Teva
Glenmark
Aurobindo
AvKare
Novartis
Sebela
Bayer

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Tinea Corporis Drugs
1.2 Classification of Tinea Corporis Drugs by Type
1.2.1 Overview: Global Tinea Corporis Drugs Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Tinea Corporis Drugs Revenue Market Share by Type in 2020
1.2.3 Antifungals
1.2.4 Steroids
1.2.5 Anti-Infective Combinations
1.3 Global Tinea Corporis Drugs Market by Application
1.3.1 Overview: Global Tinea Corporis Drugs Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Tinea Corporis Drugs Market Size & Forecast
1.5 Global Tinea Corporis Drugs Market Size and Forecast by Region
1.5.1 Global Tinea Corporis Drugs Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Tinea Corporis Drugs Market Size by Region, (2016-2021)
1.5.3 North America Tinea Corporis Drugs Market Size and Prospect (2016-2026)
1.5.4 Europe Tinea Corporis Drugs Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Tinea Corporis Drugs Market Size and Prospect (2016-2026)
1.5.6 South America Tinea Corporis Drugs Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Tinea Corporis Drugs Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Tinea Corporis Drugs Market Drivers
1.6.2 Tinea Corporis Drugs Market Restraints
1.6.3 Tinea Corporis Drugs Trends Analysis
2 Company Profiles
2.1 Sun Pharmaceutical
2.1.1 Sun Pharmaceutical Details
2.1.2 Sun Pharmaceutical Major Business
2.1.3 Sun Pharmaceutical Tinea Corporis Drugs Product and Solutions
2.1.4 Sun Pharmaceutical Tinea Corporis Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Sun Pharmaceutical Recent Developments and Future Plans
2.2 Teva
2.2.1 Teva Details
2.2.2 Teva Major Business
2.2.3 Teva Tinea Corporis Drugs Product and Solutions
2.2.4 Teva Tinea Corporis Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Teva Recent Developments and Future Plans
2.3 Glenmark
2.3.1 Glenmark Details
2.3.2 Glenmark Major Business
2.3.3 Glenmark Tinea Corporis Drugs Product and Solutions
2.3.4 Glenmark Tinea Corporis Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Glenmark Recent Developments and Future Plans
2.4 Aurobindo
2.4.1 Aurobindo Details
2.4.2 Aurobindo Major Business
2.4.3 Aurobindo Tinea Corporis Drugs Product and Solutions
2.4.4 Aurobindo Tinea Corporis Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Aurobindo Recent Developments and Future Plans
2.5 AvKare
2.5.1 AvKare Details
2.5.2 AvKare Major Business
2.5.3 AvKare Tinea Corporis Drugs Product and Solutions
2.5.4 AvKare Tinea Corporis Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 AvKare Recent Developments and Future Plans
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Tinea Corporis Drugs Product and Solutions
2.6.4 Novartis Tinea Corporis Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Novartis Recent Developments and Future Plans
2.7 Sebela
2.7.1 Sebela Details
2.7.2 Sebela Major Business
2.7.3 Sebela Tinea Corporis Drugs Product and Solutions
2.7.4 Sebela Tinea Corporis Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Sebela Recent Developments and Future Plans
2.8 Bayer
2.8.1 Bayer Details
2.8.2 Bayer Major Business
2.8.3 Bayer Tinea Corporis Drugs Product and Solutions
2.8.4 Bayer Tinea Corporis Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Bayer Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Tinea Corporis Drugs Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Tinea Corporis Drugs Players Market Share
3.2.2 Top 10 Tinea Corporis Drugs Players Market Share
3.2.3 Market Competition Trend
3.3 Tinea Corporis Drugs Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Tinea Corporis Drugs Revenue and Market Share by Type (2016-2021)
4.2 Global Tinea Corporis Drugs Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Tinea Corporis Drugs Revenue Market Share by Application (2016-2021)
5.2 Tinea Corporis Drugs Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Tinea Corporis Drugs Revenue by Type (2016-2026)
6.2 North America Tinea Corporis Drugs Revenue by Application (2016-2026)
6.3 North America Tinea Corporis Drugs Market Size by Country
6.3.1 North America Tinea Corporis Drugs Revenue by Country (2016-2026)
6.3.2 United States Tinea Corporis Drugs Market Size and Forecast (2016-2026)
6.3.3 Canada Tinea Corporis Drugs Market Size and Forecast (2016-2026)
6.3.4 Mexico Tinea Corporis Drugs Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Tinea Corporis Drugs Revenue by Type (2016-2026)
7.2 Europe Tinea Corporis Drugs Revenue by Application (2016-2026)
7.3 Europe Tinea Corporis Drugs Market Size by Country
7.3.1 Europe Tinea Corporis Drugs Revenue by Country (2016-2026)
7.3.2 Germany Tinea Corporis Drugs Market Size and Forecast (2016-2026)
7.3.3 France Tinea Corporis Drugs Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Tinea Corporis Drugs Market Size and Forecast (2016-2026)
7.3.5 Russia Tinea Corporis Drugs Market Size and Forecast (2016-2026)
7.3.6 Italy Tinea Corporis Drugs Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Tinea Corporis Drugs Revenue by Type (2016-2026)
8.2 Asia-Pacific Tinea Corporis Drugs Revenue by Application (2016-2026)
8.3 Asia-Pacific Tinea Corporis Drugs Market Size by Region
8.3.1 Asia-Pacific Tinea Corporis Drugs Revenue by Region (2016-2026)
8.3.2 China Tinea Corporis Drugs Market Size and Forecast (2016-2026)
8.3.3 Japan Tinea Corporis Drugs Market Size and Forecast (2016-2026)
8.3.4 South Korea Tinea Corporis Drugs Market Size and Forecast (2016-2026)
8.3.5 India Tinea Corporis Drugs Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Tinea Corporis Drugs Market Size and Forecast (2016-2026)
8.3.7 Australia Tinea Corporis Drugs Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Tinea Corporis Drugs Revenue by Type (2016-2026)
9.2 South America Tinea Corporis Drugs Revenue by Application (2016-2026)
9.3 South America Tinea Corporis Drugs Market Size by Country
9.3.1 South America Tinea Corporis Drugs Revenue by Country (2016-2026)
9.3.2 Brazil Tinea Corporis Drugs Market Size and Forecast (2016-2026)
9.3.3 Argentina Tinea Corporis Drugs Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Tinea Corporis Drugs Revenue by Type (2016-2026)
10.2 Middle East & Africa Tinea Corporis Drugs Revenue by Application (2016-2026)
10.3 Middle East & Africa Tinea Corporis Drugs Market Size by Country
10.3.1 Middle East & Africa Tinea Corporis Drugs Revenue by Country (2016-2026)
10.3.2 Turkey Tinea Corporis Drugs Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Tinea Corporis Drugs Market Size and Forecast (2016-2026)
10.3.4 UAE Tinea Corporis Drugs Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Tinea Corporis Drugs Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Tinea Corporis Drugs Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Tinea Corporis Drugs Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Tinea Corporis Drugs Revenue (USD Million) by Region (2016-2021)
Table 5. Global Tinea Corporis Drugs Revenue Market Share by Region (2021-2026)
Table 6. Sun Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 7. Sun Pharmaceutical Major Business
Table 8. Sun Pharmaceutical Tinea Corporis Drugs Product and Solutions
Table 9. Sun Pharmaceutical Tinea Corporis Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Teva Corporate Information, Head Office, and Major Competitors
Table 11. Teva Major Business
Table 12. Teva Tinea Corporis Drugs Product and Solutions
Table 13. Teva Tinea Corporis Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Glenmark Corporate Information, Head Office, and Major Competitors
Table 15. Glenmark Major Business
Table 16. Glenmark Tinea Corporis Drugs Product and Solutions
Table 17. Glenmark Tinea Corporis Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Aurobindo Corporate Information, Head Office, and Major Competitors
Table 19. Aurobindo Major Business
Table 20. Aurobindo Tinea Corporis Drugs Product and Solutions
Table 21. Aurobindo Tinea Corporis Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. AvKare Corporate Information, Head Office, and Major Competitors
Table 23. AvKare Major Business
Table 24. AvKare Tinea Corporis Drugs Product and Solutions
Table 25. AvKare Tinea Corporis Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Novartis Corporate Information, Head Office, and Major Competitors
Table 27. Novartis Major Business
Table 28. Novartis Tinea Corporis Drugs Product and Solutions
Table 29. Novartis Tinea Corporis Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Sebela Corporate Information, Head Office, and Major Competitors
Table 31. Sebela Major Business
Table 32. Sebela Tinea Corporis Drugs Product and Solutions
Table 33. Sebela Tinea Corporis Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Bayer Corporate Information, Head Office, and Major Competitors
Table 35. Bayer Major Business
Table 36. Bayer Tinea Corporis Drugs Product and Solutions
Table 37. Bayer Tinea Corporis Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Global Tinea Corporis Drugs Revenue (USD Million) by Players (2019-2021)
Table 39. Global Tinea Corporis Drugs Revenue Share by Players (2019-2021)
Table 40. Breakdown of Tinea Corporis Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 41. Tinea Corporis Drugs Players Head Office, Products and Services Provided
Table 42. Tinea Corporis Drugs Mergers & Acquisitions in the Past Five Years
Table 43. Tinea Corporis Drugs New Entrants and Expansion Plans
Table 44. Global Tinea Corporis Drugs Revenue (USD Million) by Type (2016-2021)
Table 45. Global Tinea Corporis Drugs Revenue Share by Type (2016-2021)
Table 46. Global Tinea Corporis Drugs Revenue Forecast by Type (2021-2026)
Table 47. Global Tinea Corporis Drugs Revenue by Application (2016-2021)
Table 48. Global Tinea Corporis Drugs Revenue Forecast by Application (2021-2026)
Table 49. North America Tinea Corporis Drugs Revenue by Type (2016-2021) & (USD Million)
Table 50. North America Tinea Corporis Drugs Revenue by Type (2021-2026) & (USD Million)
Table 51. North America Tinea Corporis Drugs Revenue by Application (2016-2021) & (USD Million)
Table 52. North America Tinea Corporis Drugs Revenue by Application (2021-2026) & (USD Million)
Table 53. North America Tinea Corporis Drugs Revenue by Country (2016-2021) & (USD Million)
Table 54. North America Tinea Corporis Drugs Revenue by Country (2021-2026) & (USD Million)
Table 55. Europe Tinea Corporis Drugs Revenue by Type (2016-2021) & (USD Million)
Table 56. Europe Tinea Corporis Drugs Revenue by Type (2021-2026) & (USD Million)
Table 57. Europe Tinea Corporis Drugs Revenue by Application (2016-2021) & (USD Million)
Table 58. Europe Tinea Corporis Drugs Revenue by Application (2021-2026) & (USD Million)
Table 59. Europe Tinea Corporis Drugs Revenue by Country (2016-2021) & (USD Million)
Table 60. Europe Tinea Corporis Drugs Revenue by Country (2021-2026) & (USD Million)
Table 61. Asia-Pacific Tinea Corporis Drugs Revenue by Type (2016-2021) & (USD Million)
Table 62. Asia-Pacific Tinea Corporis Drugs Revenue by Type (2021-2026) & (USD Million)
Table 63. Asia-Pacific Tinea Corporis Drugs Revenue by Application (2016-2021) & (USD Million)
Table 64. Asia-Pacific Tinea Corporis Drugs Revenue by Application (2021-2026) & (USD Million)
Table 65. Asia-Pacific Tinea Corporis Drugs Revenue by Region (2016-2021) & (USD Million)
Table 66. Asia-Pacific Tinea Corporis Drugs Revenue by Region (2021-2026) & (USD Million)
Table 67. South America Tinea Corporis Drugs Revenue by Type (2016-2021) & (USD Million)
Table 68. South America Tinea Corporis Drugs Revenue by Type (2021-2026) & (USD Million)
Table 69. South America Tinea Corporis Drugs Revenue by Application (2016-2021) & (USD Million)
Table 70. South America Tinea Corporis Drugs Revenue by Application (2021-2026) & (USD Million)
Table 71. South America Tinea Corporis Drugs Revenue by Country (2016-2021) & (USD Million)
Table 72. South America Tinea Corporis Drugs Revenue by Country (2021-2026) & (USD Million)
Table 73. Middle East & Africa Tinea Corporis Drugs Revenue by Type (2016-2021) & (USD Million)
Table 74. Middle East & Africa Tinea Corporis Drugs Revenue by Type (2021-2026) & (USD Million)
Table 75. Middle East & Africa Tinea Corporis Drugs Revenue by Application (2016-2021) & (USD Million)
Table 76. Middle East & Africa Tinea Corporis Drugs Revenue by Application (2021-2026) & (USD Million)
Table 77. Middle East & Africa Tinea Corporis Drugs Revenue by Country (2016-2021) & (USD Million)
Table 78. Middle East & Africa Tinea Corporis Drugs Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Tinea Corporis Drugs Picture
Figure 2. Global Tinea Corporis Drugs Revenue Market Share by Type in 2020
Figure 3. Antifungals
Figure 4. Steroids
Figure 5. Anti-Infective Combinations
Figure 6. Tinea Corporis Drugs Revenue Market Share by Application in 2020
Figure 7. Hospital Pharmacies Picture
Figure 8. Retail Pharmacies Picture
Figure 9. Online Pharmacies Picture
Figure 10. Global Tinea Corporis Drugs Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Tinea Corporis Drugs Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Tinea Corporis Drugs Revenue Market Share by Region (2016-2026)
Figure 13. Global Tinea Corporis Drugs Revenue Market Share by Region in 2020
Figure 14. North America Tinea Corporis Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Tinea Corporis Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Tinea Corporis Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Tinea Corporis Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Tinea Corporis Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Tinea Corporis Drugs Market Drivers
Figure 20. Tinea Corporis Drugs Market Restraints
Figure 21. Tinea Corporis Drugs Market Trends
Figure 22. Sun Pharmaceutical Recent Developments and Future Plans
Figure 23. Teva Recent Developments and Future Plans
Figure 24. Glenmark Recent Developments and Future Plans
Figure 25. Aurobindo Recent Developments and Future Plans
Figure 26. AvKare Recent Developments and Future Plans
Figure 27. Novartis Recent Developments and Future Plans
Figure 28. Sebela Recent Developments and Future Plans
Figure 29. Bayer Recent Developments and Future Plans
Figure 30. Global Tinea Corporis Drugs Revenue Share by Players in 2020
Figure 31. Tinea Corporis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 32. Global Top 3 Players Tinea Corporis Drugs Revenue Market Share in 2020
Figure 33. Global Top 10 Players Tinea Corporis Drugs Revenue Market Share in 2020
Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 35. Global Tinea Corporis Drugs Revenue Share by Type in 2020
Figure 36. Global Tinea Corporis Drugs Market Share Forecast by Type (2021-2026)
Figure 37. Global Tinea Corporis Drugs Revenue Share by Application in 2020
Figure 38. Global Tinea Corporis Drugs Market Share Forecast by Application (2021-2026)
Figure 39. North America Tinea Corporis Drugs Sales Market Share by Type (2016-2026)
Figure 40. North America Tinea Corporis Drugs Sales Market Share by Application (2016-2026)
Figure 41. North America Tinea Corporis Drugs Revenue Market Share by Country (2016-2026)
Figure 42. United States Tinea Corporis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada Tinea Corporis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico Tinea Corporis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe Tinea Corporis Drugs Sales Market Share by Type (2016-2026)
Figure 46. Europe Tinea Corporis Drugs Sales Market Share by Application (2016-2026)
Figure 47. Europe Tinea Corporis Drugs Revenue Market Share by Country (2016-2026)
Figure 48. Germany Tinea Corporis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. France Tinea Corporis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. United Kingdom Tinea Corporis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Russia Tinea Corporis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Italy Tinea Corporis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Asia-Pacific Tinea Corporis Drugs Sales Market Share by Type (2016-2026)
Figure 54. Asia-Pacific Tinea Corporis Drugs Sales Market Share by Application (2016-2026)
Figure 55. Asia-Pacific Tinea Corporis Drugs Revenue Market Share by Region (2016-2026)
Figure 56. China Tinea Corporis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Tinea Corporis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. South Korea Tinea Corporis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Tinea Corporis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Tinea Corporis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Tinea Corporis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Tinea Corporis Drugs Sales Market Share by Type (2016-2026)
Figure 63. South America Tinea Corporis Drugs Sales Market Share by Application (2016-2026)
Figure 64. South America Tinea Corporis Drugs Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Tinea Corporis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Tinea Corporis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East and Africa Tinea Corporis Drugs Sales Market Share by Type (2016-2026)
Figure 68. Middle East and Africa Tinea Corporis Drugs Sales Market Share by Application (2016-2026)
Figure 69. Middle East and Africa Tinea Corporis Drugs Revenue Market Share by Country (2016-2026)
Figure 70. Turkey Tinea Corporis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Saudi Arabia Tinea Corporis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. UAE Tinea Corporis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Methodology
Figure 74. Research Process and Data Source

---